Company Analysis Bristol-Myers
1. Summary
Advantages
- Dividends (4.56%) are higher than the sector average (1.31%).
- The stock's return over the last year (13.6%) is higher than the sector average (-18.38%).
- The company's current efficiency (ROE=27.27%) is higher than the sector average (ROE=-82.41%)
Disadvantages
- Price (59.81 $) is higher than fair price (50.82 $)
- Current debt level 41.97% has increased over 5 years from 36.59%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
18 november 17:57 Western drugmakers are still providing medicines to Russia
18 november 17:51 Drugmakers raised prices by 6.6% on average early this year
18 november 16:20 Biden pushes Congress to allow Medicare to negotiate drug prices
2.3. Market efficiency
| Bristol-Myers | Healthcare | Index | |
|---|---|---|---|
| 7 days | -0.6% | -13.3% | 2.7% |
| 90 days | 6.3% | -13% | -4.5% |
| 1 year | 13.6% | -18.4% | 10% |
BMY vs Sector: Bristol-Myers has outperformed the "Healthcare" sector by 31.98% over the past year.
BMY vs Market: Bristol-Myers has outperformed the market by 3.56% over the past year.
Stable price: BMY is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BMY with weekly volatility of 0.2615% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (59.81 $) is higher than the fair price (50.82 $).
Price is higher than fair: The current price (59.81 $) is 15% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (13.54) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (13.54) is lower than that of the market as a whole (73.05).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.69) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (3.69) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.41) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (2.41) is lower than that of the market as a whole (15.91).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (7.23) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (7.23) is lower than that of the market as a whole (23.05).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -37.83% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-37.83%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (27.27%) is higher than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (27.27%) is higher than that of the market as a whole (25.12%).
5.5. ROA
ROA vs Sector: The company's ROA (8.43%) is higher than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (8.43%) is higher than that of the market as a whole (6.65%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (9.09%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (9.09%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 4.56% is higher than the average for the sector '1.31%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 4.56% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 4.56% has been growing over the last 5 years. Growth over 10 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (59.12%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
